Antiviral phenylpropanoid glycosides from the medicinal plant Markhamia lutea

被引:87
作者
Kernan, MR
Amarquaye, A
Chen, JL
Chan, J
Sesin, DF
Parkinson, N
Ye, ZJ
Barrett, M
Bales, C
Stoddart, CA
Blanc, P
Sloan, B
Limbach, C
Mrisho, S
Rozhon, EJ
机构
[1] Shaman Pharmaceut, S San Francisco, CA 94080 USA
[2] Rural Dev Assoc, Tanga AIDS Working Grp, Tanga, Tanzania
来源
JOURNAL OF NATURAL PRODUCTS | 1998年 / 61卷 / 05期
关键词
D O I
10.1021/np9703914
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Three new phenylpropanoid glycosides, named luteoside A (3), luteoside B (4), and luteoside C (5), were isolated together with the known compounds verbascoside (1) and isoverbascoside (2) from the roots of the medicinal plant Markhamia lutea. The structures of the new compounds were determined to be 1-O-(3,4-dihydroxyphenyl)ethyl beta-D-apiofuranosyl(1-->2)-alpha-L-rhamnopyranosyl(1-->3)-4-O-caffeoyl-6-acetyl- beta-D-glucopyranoside, 1-O-(3,4-dihydroxyphenyl)ethyl beta-D-apiofuranosyl(1-->2)-alpha-L-rhamnopyranosyl(1-->3)-6-O-caffeoyl-beta-D-glucopyranoside, and 1-O-(3,4-dihydroxyphenyl)ethyl beta-D-apiofuranosyl(1-->2)-alpha-L-rhamnopyranosyl(1-->3)-6-O-feruloyl-beta-D-glucopyranoside, respectively, on the basis of chemical and spectroscopic data. All five phenylpropanoid glycosides exhibited potent in vitro activity against respiratory syncytial virus.
引用
收藏
页码:564 / 570
页数:7
相关论文
共 18 条
  • [1] ANDRAY C, 1982, PHYTOCHEMISTRY, V21, P1123
  • [2] CAVENAUGH PR, 1990, INVEST NEW DRUGS, V8, P347
  • [3] CAFFEOYL CONJUGATES FROM ECHINACEA SPECIES - STRUCTURES AND BIOLOGICAL-ACTIVITY
    CHEMINAT, A
    ZAWATZKY, R
    BECKER, H
    BROUILLARD, R
    [J]. PHYTOCHEMISTRY, 1988, 27 (09) : 2787 - 2794
  • [4] Cometa F., 1993, Fitoterapia, V64, P195
  • [5] MYRICOSIDE, AN AFRICAN ARMYWORM ANTIFEEDANT - SEPARATION BY DROPLET COUNTERCURRENT CHROMATOGRAPHY
    COOPER, R
    SOLOMON, PH
    KUBO, I
    NAKANISHI, K
    SHOOLERY, JN
    OCCOLOWITZ, JL
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1980, 102 (27) : 7953 - 7955
  • [6] ENDO K, 1982, HETEROCYCLES, V19, P261
  • [7] HALL CB, 1995, INFECT DIS, P1501
  • [8] KASAI R, 1991, CHEM PHARM BULL, V39, P927, DOI 10.1248/cpb.39.927
  • [9] KING S, 1994, CIBA FDN S, V195, P197
  • [10] KING SR, 1995, INTERCIENCIA, V20, P134